Theravance Reviews

5 Reviews
3.4
5 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Theravance President, CEO, and Director Rick E. Winningham
Rick E. Winningham
3 Ratings
  1.  

    Sceintist

    • Comp & Benefits
    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    Former Employee - Anonymous Employee
    Former Employee - Anonymous Employee

    I worked at Theravance

    Pros

    Great place to work; competitive; good work environment

    Cons

    Top heavy; few opportunities for growth

    Recommends
    Approves of CEO

Theravance Interviews

Interview Experience

Interview Experience

0%
33%
66%

Getting an Interview

Getting an Interview

100%

Interview Difficulty

3.3
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Assistant Controller Interview

    Anonymous Employee in South San Francisco, CA
    Anonymous Employee in South San Francisco, CA
    Application Details

    The process took 2+ weeksinterviewed at Theravance in January 2011.

    Interview Details

    I interviewed with a couple of minority women who were interested more in what shoes I was wearing and what hand bag i was carrying that my job skills. It was hard to make of what kind of culture they have here. Appearances seem to be important. Obviously I didn't get the position, but so be it.

    Interview Questions
    No Offer
    Negative Experience
    Average Interview

Theravance Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.theravance.com
Headquarters South San Francisco, CA
Size 150 to 499 Employees
Founded 1996
Type Company - Public (THRX)
Industry Biotech & Pharmaceuticals
Revenue $1 to $5 million (USD) per year

Theravance figures there's no sense in re-inventing the wheel. The biotechnology firm takes aim at already proven biological targets, taking advantage of previous years of research to create more effective, next-generation treatments. Its development programs focus on respiratory disease, bacterial infections, and gastrointestinal and neurological conditions. Its sole marketed product, VIBATIV (an injectable antibiotic approved to treat skin infections and hospital-acquired pneumonia) was successfully developed and commercialized with partner Astellas. In an exclusive... More

Work at Theravance? Share Your Experiences

Theravance

 
Click to Rate
or